Highlights for June 2018Cipla partners with Eli Lilly to market Lilly’s insulin glargine injection, Basaglar, in India.Lupin has tied up with J...
Read MoreHighlights for May 2018Aurobindo Pharma launches $1.6B bid to buy Novartis generics unit which includes an array of dermatology brands, prod...
Read MoreHighlights for April 2018Glenmark enters licensing pact with Helsinn for its chemo-induced nausea drug.Chrys Capital-led consortium set to buy 10...
Read MoreHighlights for March 2018Zydus Cadila partners with Medicure to commercialize its 505(b)(2) New Drug Application product, pitavastatin magnesium ...
Read MoreHighlights for February 2018Cipla ties up with Roche to sell two key drugs Tocilizumab and Syndyma in IndiaAlkem Labs signs pact to market S...
Read MoreHighlights for January 2018Recipharm acquires remaining shares in Nitin Lifesciences Ltd worth $44 Million.Ipca Labs acquires US drugmaker Pisgah for ...
Read MoreHighlights for December 2017Cipla sells its Croatian indirect subsidiary to PharmaS for $1.1 millionTorrent Pharma completes acquisition of Unichem's ...
Read MoreHighlights for November 2017Piramal acquires Digeplex from Shreya LifesciencesMorepen signs agreement with Vesale PharmaEris Life to acquire Strides' ...
Read MoreHighlights for October 2017Lupin acquires Symbiomix for $150 million with $50 million upfront payment.Cadila Pharmaceuticals Ltd. and Altus Formulatio...
Read MoreHighlights for September 2017Zydus Cadila inks deal to produce varicella vaccine in RussiaFosun now aims for smaller Gland Pharma stake in $1.1B dealP...
Read More